Literature DB >> 28692196

Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy.

E Al-Obeidi1, S Al-Tahan1, A Surampalli1, N Goyal2, A K Wang2, A Hermann3, M Omizo4, C Smith5, T Mozaffar2, V Kimonis1.   

Abstract

Mutations in valosin-containing protein (VCP), an ATPase involved in protein degradation and autophagy, cause VCP disease, a progressive autosomal dominant adult onset multisystem proteinopathy. The goal of this study is to examine if phenotypic differences in this disorder could be explained by the specific gene mutations. We therefore studied 231 individuals (118 males and 113 females) from 36 families carrying 15 different VCP mutations. We analyzed the correlation between the different mutations and prevalence, age of onset and severity of myopathy, Paget's disease of bone (PDB), and frontotemporal dementia (FTD), and other comorbidities. Myopathy, PDB and FTD was present in 90%, 42% and 30% of the patients, respectively, beginning at an average age of 43, 41, and 56 years, respectively. Approximately 9% of patients with VCP mutations had an amyotrophic lateral sclerosis (ALS) phenotype, 4% had been diagnosed with Parkinson's disease (PD), and 2% had been diagnosed with Alzheimer's disease (AD). Large interfamilial and intrafamilial variation made establishing correlations difficult. We did not find a correlation between the mutation type and the incidence of any of the clinical features associated with VCP disease, except for the absence of PDB with the R159C mutation in our cohort and R159C having a later age of onset of myopathy compared with other molecular subtypes.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990VCP; IBMPFD; genotype-phenotype; multisystem proteinopathy (MSP); valosin-containing protein

Mesh:

Substances:

Year:  2018        PMID: 28692196      PMCID: PMC5739971          DOI: 10.1111/cge.13095

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  57 in total

1.  Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly.

Authors:  M Hetzer; H H Meyer; T C Walther; D Bilbao-Cortes; G Warren; I W Mattaj
Journal:  Nat Cell Biol       Date:  2001-12       Impact factor: 28.824

2.  The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol.

Authors:  Y Ye; H H Meyer; T A Rapoport
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

3.  Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone.

Authors:  M Rape; T Hoppe; I Gorr; M Kalocay; H Richly; S Jentsch
Journal:  Cell       Date:  2001-11-30       Impact factor: 41.582

4.  The AAA-ATPase Cdc48/p97 regulates spindle disassembly at the end of mitosis.

Authors:  Kan Cao; Reiko Nakajima; Hemmo H Meyer; Yixian Zheng
Journal:  Cell       Date:  2003-10-31       Impact factor: 41.582

Review 5.  p97/p47-Mediated biogenesis of Golgi and ER.

Authors:  Keiji Uchiyama; Hisao Kondo
Journal:  J Biochem       Date:  2005-02       Impact factor: 3.387

6.  AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation.

Authors:  Efrat Rabinovich; Anat Kerem; Kai-Uwe Fröhlich; Noam Diamant; Shoshana Bar-Nun
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.

Authors:  M J Kovach; B Waggoner; S M Leal; D Gelber; R Khardori; M A Levenstien; C A Shanks; G Gregg; M T Al-Lozi; T Miller; W Rakowicz; G Lopate; J Florence; G Glosser; Z Simmons; J C Morris; M P Whyte; A Pestronk; V E Kimonis
Journal:  Mol Genet Metab       Date:  2001-12       Impact factor: 4.797

8.  Structural diversity and functional implications of the eukaryotic TDP gene family.

Authors:  Hurng-Yi Wang; I-Fan Wang; Jayaramakrishnan Bose; C-K James Shen
Journal:  Genomics       Date:  2004-01       Impact factor: 5.736

9.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.

Authors:  Giles D J Watts; Jill Wymer; Margaret J Kovach; Sarju G Mehta; Steven Mumm; Daniel Darvish; Alan Pestronk; Michael P Whyte; Virginia E Kimonis
Journal:  Nat Genet       Date:  2004-03-21       Impact factor: 38.330

10.  Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone.

Authors:  V E Kimonis; M J Kovach; B Waggoner; S Leal; A Salam; L Rimer; K Davis; R Khardori; D Gelber
Journal:  Genet Med       Date:  2000 Jul-Aug       Impact factor: 8.822

View more
  32 in total

1.  A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.

Authors:  Jake Plewa; Abhilasha Surampalli; Marie Wencel; Merit Milad; Sandra Donkervoort; Vincent J Caiozzo; Namita Goyal; Tahseen Mozaffar; Virginia Kimonis
Journal:  Neuromuscul Disord       Date:  2018-06-27       Impact factor: 4.296

Review 2.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

3.  VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle.

Authors:  Khalid Arhzaouy; Chrisovalantis Papadopoulos; Nina Schulze; Sara K Pittman; Hemmo Meyer; Conrad C Weihl
Journal:  Autophagy       Date:  2019-01-29       Impact factor: 16.016

Review 4.  Modulating protein-protein interaction networks in protein homeostasis.

Authors:  Mengqi Zhong; Gregory M Lee; Eline Sijbesma; Christian Ottmann; Michelle R Arkin
Journal:  Curr Opin Chem Biol       Date:  2019-03-23       Impact factor: 8.822

5.  A clinicopathologic study of malignancy in VCP-associated multisystem proteinopathy.

Authors:  Alyaa Shmara; Mari Perez-Rosendahl; Kady Murphy; Ashley Kwon; Charles Smith; Virginia Kimonis
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

6.  CRISPR/Cas9-Mediated Constitutive Loss of VCP (Valosin-Containing Protein) Impairs Proteostasis and Leads to Defective Striated Muscle Structure and Function In Vivo.

Authors:  Philipp Voisard; Federica Diofano; Amelia A Glazier; Wolfgang Rottbauer; Steffen Just
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

7.  TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations.

Authors:  YouJin Lee; Per Harald Jonson; Jaakko Sarparanta; Johanna Palmio; Mohona Sarkar; Anna Vihola; Anni Evilä; Tiina Suominen; Sini Penttilä; Marco Savarese; Mridul Johari; Marie-Christine Minot; David Hilton-Jones; Paul Maddison; Patrick Chinnery; Jens Reimann; Cornelia Kornblum; Torsten Kraya; Stephan Zierz; Carolyn Sue; Hans Goebel; Asim Azfer; Stuart H Ralston; Peter Hackman; Robert C Bucelli; J Paul Taylor; Conrad C Weihl; Bjarne Udd
Journal:  J Clin Invest       Date:  2018-02-19       Impact factor: 14.808

8.  Multisystem Proteinopathy Mutations in VCP/p97 Increase NPLOC4·UFD1L Binding and Substrate Processing.

Authors:  Emily E Blythe; Stephanie N Gates; Raymond J Deshaies; Andreas Martin
Journal:  Structure       Date:  2019-10-14       Impact factor: 5.006

9.  Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.

Authors:  Manuela Neumann; Edward B Lee; Ian R Mackenzie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions.

Authors:  Ernesto Estrada
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.